This is the authors' abstract. We don't add key points for this paper.
Objective Current pre‑endoscopic evaluation relies primarily on the American Society of Anesthesiologists (ASA) physical status classification, which does not adequately identify modifiable risk factors such as hypovolaemia and electrolyte imbalances. This study investigated whether supplementing the standard workup with point‑of‑care ultrasound for volume assessment and bedside electrolyte monitoring—thereby establishing a preoperative precision evaluation system with targeted interventions—could reduce the incidence of anaesthesia‑related perioperative adverse events in elderly patients undergoing painless gastrointestinal endoscopy. Methods This prospective, randomised, controlled, single‑centre study enrolled 204 patients (both sexes, aged > 65 years, ASA II–III) scheduled for painless gastrointestinal endoscopy. Patients were randomly allocated via a random number table to an experimental group (Group E, n = 102) or a control group (Group C, n = 102). Both groups underwent preoperative assessments including the Edmonton Frail Scale (EFS), ultrasound measurement of inferior vena cava diameter and collapsibility index (IVC‑CI), and point‑of‑care testing of electrolytes and glucose. In Group E, predefined intervention criteria were applied, while Group C received the routine protocol without additional intervention. The primary outcome was the composite incidence of anaesthesia‑related adverse events. Results Compared with Group C, Group E showed a significantly lower incidence of at least one anaesthesia‑related adverse event (62.74% vs. 32.35%, P < 0.0001). Specifically, the incidence of hypotension decreased from 50.98% to 27.45% (P < 0.0001; RR = 0.52, 95% CI 0.36–0.74). There were no significant differences between groups in respiratory events or recovery time. Conclusion In comparison with Group C, Group E had a significantly reduced incidence of at least one anaesthesia‑related adverse event (62.74% vs. 32.35%, P < 0.0001), and the hypotension rate dropped from 50.98% to 27.45% (P < 0.0001; RR = 0.52, 95% CI 0.36–0.74). Trial registration China Clinical Trials Registry (ChiCTR2300067729)
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: